COVID-19 Vaccination and Diabetes Mellitus: How Much Has It Made a Difference to Outcomes Following Confirmed COVID-19 Infection?

[1]  N. Peek,et al.  Mortality in People with Type 2 Diabetes Following SARS-CoV-2 Infection: A Population Level Analysis of Potential Risk Factors , 2022, Diabetes Therapy.

[2]  N. Peek,et al.  The Risk Factors Potentially Influencing Hospital Admission in People with Diabetes, Following SARS-CoV-2 Infection: A Population-Level Analysis , 2022, Diabetes Therapy.

[3]  J. Brainard,et al.  Was Alpha deadlier than wild-type COVID? Analysis in rural England , 2022, Infection.

[4]  M. Ramsay,et al.  Characteristics associated with COVID-19 vaccine uptake among adults aged 50 years and above in England (8 December 2020–17 May 2021): a population-level observational study , 2022, BMJ Open.

[5]  K. Khunti,et al.  Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study , 2021, BMJ.

[6]  W. Ollier,et al.  Age of people with type 2 diabetes and the risk of dying following SARS‐CoV‐2 infection , 2021, International journal of clinical practice.

[7]  S. Bhadada,et al.  COVID-19 vaccination in patients with diabetes mellitus: Current concepts, uncertainties and challenges , 2021, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[8]  K. Khunti,et al.  Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study , 2020, The Lancet Diabetes & Endocrinology.

[9]  A. Boulton,et al.  COVID-19 and diabetes: International Diabetes Federation perspectives , 2020, Diabetes Research and Clinical Practice.

[10]  K. Bhaskaran,et al.  OpenSAFELY: factors associated with COVID-19 death in 17 million patients , 2020, Nature.

[11]  C. Cuspidi,et al.  COVID‐19 and diabetes: Is there enough evidence? , 2020, Journal of clinical hypertension.

[12]  D. Matthews,et al.  Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature , 2020, Diabetologia.

[13]  S. Anderson,et al.  A phased approach to unlocking during the COVID‐19 pandemic—Lessons from trend analysis , 2020, medRxiv.

[14]  4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2020 , 2019, Diabetes Care.

[15]  B. Jarman,et al.  Measuring disadvantage: changes in the underprivileged area, Townsend, and Carstairs scores 1981-91. , 1995, Journal of epidemiology and community health.

[16]  Steven A. Smith,et al.  Use of influenza and pneumococcal vaccines in people with diabetes. , 2000, Diabetes care.